Glycopeptide derivatives and pharmaceutical compositions...

Details Glycopeptide derivatives and pharmaceutical compositions... Glycopeptide derivatives and pharmaceutical compositions...

2005-11-08

2005-11-08

Lukton, David (Department: 1653)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Cyclic peptides

C514S008100, C514S011400, C530S322000

Reexamination Certificate

active

06962970

ABSTRACT:
Disclosed are derivatives of glycopeptide compounds having at least one substituent of the formula:in-line-formulae description="In-line Formulae" end="lead"?—Ra—Y—Rb—(Z)xin-line-formulae description="In-line Formulae" end="tail"?where Ra, Rb, Y, Z and x are as defined, and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

REFERENCES:
patent: 4497802 (1985-02-01), Debono
patent: 4639433 (1987-01-01), Hunt et al.
patent: 4643987 (1987-02-01), Nagarajan et al.
patent: 4661470 (1987-04-01), Malabarba et al.
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: 4914187 (1990-04-01), Malabarba et al.
patent: 5534420 (1996-07-01), Debono et al.
patent: 5591714 (1997-01-01), Nagarajan et al.
patent: 5750509 (1998-05-01), Malabarba et al.
patent: 5840684 (1998-11-01), Cooper et al.
patent: 5843889 (1998-12-01), Cooper et al.
patent: 5916873 (1999-06-01), Cooper et al.
patent: 5919756 (1999-07-01), Cooper et al.
patent: 5952310 (1999-09-01), Thompson et al.
patent: 5952466 (1999-09-01), Berglund et al.
patent: 5977062 (1999-11-01), Cooper et al.
patent: 5977063 (1999-11-01), Thompson et al.
patent: 5998581 (1999-12-01), Berglund et al.
patent: 0 182 157 (1986-05-01), None
patent: 0 351 597 (1990-01-01), None
patent: 0 376 041 (1990-07-01), None
patent: 0 460 448 (1991-12-01), None
patent: 0 525 499 (1993-02-01), None
patent: 0 596 929 (1995-07-01), None
patent: 0 667 353 (1995-08-01), None
patent: 0 801 075 (1997-10-01), None
patent: 0 802 199 (1997-10-01), None
patent: 0 816 378 (1998-01-01), None
patent: WO 88/06600 (1988-09-01), None
patent: WO 90/11300 (1990-10-01), None
patent: WO 97/28812 (1997-08-01), None
patent: WO 97/34623 (1997-09-01), None
patent: WO 97/38702 (1997-10-01), None
patent: WO 97/40067 (1997-10-01), None
patent: WO 98/21952 (1998-05-01), None
patent: WO 98/52589 (1998-11-01), None
patent: WO 98/52592 (1998-11-01), None
patent: WO 99/42476 (1999-08-01), None
patent: WO 99/56760 (1999-11-01), None
patent: WO 00/04044 (2000-01-01), None
Allen et al., “The Role of Hydrophobic Side Chains as Determinants of Antibacterial Activity of Semisynthetic Glycopeptide Antibiotics”, The Journal of Antibiotics, vol. 50, No. 8, pp 677-684 (1997).
Axelsen et al., “A Rational Strategy for Enhancing the Affinity of Vancomycin towards Depsipeptide Ligands”, Bioorganic & Medicinal Chemistry 6, pp 877-881 (1998).
Booth et al., “The Edman Degradation of Vancomycin: Preparation of Vancomycin Hexapeptide”, J. Chem. Soc., Chem. Commun., pp 1694-1695 (1987).
Cooper et al., “Reductive Alkylation of Glycopeptide Antibiotics:Synthesis and Antibacterial Activity”, vol. 49, No. 6, pp 575-581 (1996).
Cooper et al., “Chapter 14. Semisynthetic Glycopeptide Antibiotics”, Annual Reports in Medicinal Chemistry, vol. 31, pp 131-140 (1996).
Fukuzawa et al., “Modification of sugar part of glycopeptide antibiotic, vancomycin”, Tennen Yuki Kagobutsu Toronkai Koen Yoshishua, 40th, pp 151-156 (1998) (in Japanese with English language translation).
GE et al., “Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding D-Ala-D-Ala”, Science, vol. 284, pp 507-511 (1999).
Kerns et al., “Synthesis and Antibacterial Activity of Novel Carbohydrate Modified Derivatives of the Glycopeptide Antibiotic Vancomycin”, Abstracts of Papers of the 216th ACS National Meeting, Boston, MA, Aug. 23-27, 1998.
MacKay et al., “Glycopeptide Antibiotic Activity and the Possible Role of Dimerization: A Model for Biological Signaling”, J. Am. Chem. Soc., vol. 116, pp 4581-4590 (1994).
Malabarba et al., “Amides of De-Acetylglucosaminyl-Deoxy Teicoplanin Active Against Highly Glycopeptide-Resistant Enterococci”, vol. 47, No. 12, pp 1493-1506 (1994).
Malabarba et al., “Glycopeptide resistance in multiple antibiotic-resistant Gram-positive bacteria; a current challenge for novel semi-synthetic glycopeptide derivatives”, Eur. J. Med. Chem., vol. 32, pp 459-478 (1997).
Malabarba et al., “New Semisynthetic Glycopeptides MDL 63,246 and MDL 63,042, and Other Amide Derivatives of Antibiotic A-40,926 against Highly Glycopeptide-resistant VanA Enterococci”, The Journal of Antibiotics, vol. 48, No. 8, pp 869-883 (1995).
Malabarba et al., “Reductive Hydrolysis of the 59,60-Amide Bond of Teicoplanin Antibiotics: A Key Step from Natural to Synthetic Glycopeptides”, J. Med. Chem., vol. 37, pp 2988-2990 (1994).
Malabarba et al., “Structural Modifications of the Active Site in Teicoplanin and Related Glycopeptides. 1. Reductive Hydrolysis of the 1,2- and 2,3-Peptide Bonds”, J. Org. Chem., vol. 61, pp 2137-2150 (1996).
Malabarba et al., “Substitution of Amino Acids 1 and 3 in Teicoplanin Aglycon: Synthesis and Antibacterical Activity of Three First Non-natural Dalbaheptides”, The Journal of Antibiotics, vol. 50, pp 70-81 (1997).
Malabarba et al., “Synthesis and Biological Activity of Some Esters of the N-Acetylglucosaminyl Aglycone and of the Aglycone of Teicoplanin”, The Journal of Antibiotics, vol. XL, No. 11, pp 1572-1587 (1987).
Malabarba et al., “Synthesis and Biological Properties of N63-Carboxamides of Teicoplanin Antibiotics. Structure-Activity Relationships”, J. Med. Chem., vol. 32, pp 2450-2460 (1989).
Nagarajan, “Structure-Activity Relationships of Vancoymycin-Type Glycopeptide Antibiotics”, The Journal of Antibiotics, vol. 46, No. 8, pp 1181-1195 (1993).
Nagarajan et al., “Synthesis and Antibacterial Activity of N-cyAl Vancomycins”, The Journal of Antibiotics, vol. XLI, No. 10, pp 1430-1438 (1988).
Nagarajan et al., “Synthesis and Antibacterial Evaluation of N-Alkyl Vancomycins”, The Journal of Antibiotics, vol. XLII, No. 1, pp 63-72 (1989).
Nicolaou et al., “Chemistry, Biology, and Medicine of the Glycopeptides Antibiotics”, Angew. Chem. Int. Ed., vol. 38, pp 2096-2152 (1999).
Olsufyeva et al., “Chemical Modification of Antibiotic Eremomycin at the Asparagine Side Chain”, The Journal of Antibiotics, vol. 52, No. 3, pp 319-324 (1999).
Pavlov et al., “A New Type of Chemical Modification of Glycopeptides Antibiotics:Aminomethylated Derivatives of Eremomycin and Their Antibacterial Activity”, The Journal of Antibiotics, vol. 50, No. 6, pp 509-513 (1997).
Pavlov et al., Chemical Modication of Glycopeptide Antibiotics [VC1], Russian Journal of Biooganic Chemistry, vol. 24, No. 9, pp 570-587 (1998).
Pavlov et al., “Mono and Double Modified Teicoplanin Aglycon Derivatives on the Amino Acid No. 7; Structure-activity Relationship”, The Journal of Antibiotics, vol. 51, No. 1, pp 73-78 (1997).
Rodriguez et al., “Novel Glycopeptide Antibiotics:N-Alkylated Derivatives Active Against Vancomycin-Resistant Enterococci”, vol. 51, No. 6, pp 560-569 (1998).
Sharman et al., “The Roles of Dimerization and Membrane Anchoring in Activity of Glycopeptide Antibiotics against Vancomycin-Resistant Bacteria”, J. Am. Chem. Soc., vol. 119, pp 12041-12047 (1997).
Snyder et al., “Enzymatic Deacylation of Telcoplanin Followed by Reductive Alkylation:Synthesis and Antibacterial Activity of New Glycopeptides”, The Journal of Antibiotics, vol. 51, No. 10, pp 945-951 (1998).
Staroske et al., “Synthesis of Covalent Head-to-Tail Dimers of Vancomycin”, Tetrahedron Letters 39, pp 4917-4920 (1998).
Sundram et al., “Novel Vancomycin Dimers with Activity against Vancomycin-Resistant Enterococci”, J. Am. Chem. Soc., vol. 118, pp 13107-13108 (1996).

Affiliated with

Also associated with

Rating

Glycopeptide derivatives and pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycopeptide derivatives and pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycopeptide derivatives and pharmaceutical compositions... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3513918